Filters close
Newswise: Albert Einstein College of Medicine Names Yoon Kang, M.D., Vice Dean for Education
Released: 7-May-2024 9:00 AM EDT
Albert Einstein College of Medicine Names Yoon Kang, M.D., Vice Dean for Education
Albert Einstein College of Medicine

Albert Einstein College of Medicine has appointed nationally recognized education leader Yoon Kang, M.D., as its inaugural vice dean for education, following a national search.

Newswise: Asthma Education is Key to Reducing Deaths Worldwide, Say Respiratory Health Associations
Released: 7-May-2024 9:00 AM EDT
Asthma Education is Key to Reducing Deaths Worldwide, Say Respiratory Health Associations
American Thoracic Society (ATS)

On World Asthma Day 2024 the message is clear: "Asthma Education Empowers." The Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, stresses the crucial role of education in empowering people with asthma to manage their condition effectively and to know when to seek medical assistance.

Newswise: 60% of Women with Disabilities View Cannabis as a ‘Harmless’ Drug
Released: 7-May-2024 8:30 AM EDT
60% of Women with Disabilities View Cannabis as a ‘Harmless’ Drug
Florida Atlantic University

In women of childbearing age, cannabis use may increase the risk of adverse reproductive and perinatal health outcomes. A study in a sample of 20,234 women ages 18 to 49 by disability status showed that about 60% of women with disabilities who used cannabis in the past 12 months perceived no risk of harm from weekly cannabis use.

Released: 7-May-2024 7:00 AM EDT
New Study Finds Increase in Exposures to Synthetic Tetrahydrocannabinols Among Young Children, Teens, and Adults
Nationwide Children's Hospital

A sharp rise in exposures to synthetic cannabis products among youth — some leading to hospitalization — highlights the need for increased education around the dangers of exposure and increased focus on safe storage and packaging, according to pediatricians and researchers at Nationwide Children’s Hospital and the Central Ohio Poison Center.

Newswise: 1920_yom-hashoah-cedars-sinai.jpg?10000
Released: 6-May-2024 6:05 PM EDT
Holocaust Remembrance Day: Gift Funds Annual Observance and Lecture
Cedars-Sinai

Cedars-Sinai remembers. On Yom Ha’Shoah, also known as Holocaust Remembrance Day, the medical center solemnly honored the six million Jews, and millions of others, who perished under Nazi rule, one of the darkest periods in history.

Released: 6-May-2024 6:00 PM EDT
New research confirms that Beethoven had lead poisoning — but it didn’t kill him
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

To this day, no one knows for certain what caused the liver and kidney disease that led to Ludwig van Beethoven’s untimely death. However, a new letter to the editor in the Association for Diagnostics & Laboratory Medicine’s (ADLM’s, formerly AACC’s) journal Clinical Chemistry rules out one popular theory, showing that the composer was exposed to lead levels that were high — but not high enough to kill him.

Not for public release

This news release is embargoed until 6-May-2024 5:00 PM EDT Released to reporters: 30-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 6-May-2024 5:00 PM EDT Released to reporters: 30-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 6-May-2024 5:00 PM EDT Released to reporters: 30-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-May-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: 1920_heart-examination-cedars-sinai.jpg?10000
Released: 6-May-2024 4:05 PM EDT
AI May Help Physicians Detect Abnormal Heart Rhythms Earlier
Cedars-Sinai

An artificial intelligence (AI) program developed by investigators in the Smidt Heart Institute and their Cedars-Sinai colleagues can detect a type of abnormal heart rhythm that can go unnoticed during medical appointments, according to a new study.

Released: 6-May-2024 3:05 PM EDT
Tiny displacements, giant changes in optical properties
Washington University in St. Louis

In a study published online March 23 in Advanced Materials, researchers from Washington University in St. Louis and University of Southern California reveal a new pathway for designing optical materials using the degree of atomic disorder. The researchers anticipate developing crystals that enable advanced infrared imaging in low light conditions, or to enhance medical imaging devices.

Newswise: Sylvester Researchers Develop a Nanoparticle That Can Penetrate the Blood-Brain Barrier
2-May-2024 8:05 PM EDT
Sylvester Researchers Develop a Nanoparticle That Can Penetrate the Blood-Brain Barrier
Sylvester Comprehensive Cancer Center

Researchers at Sylvester Comprehensive Cancer Center have developed a nanoparticle that can penetrate the blood-brain barrier. Their goal is to kill primary breast cancer tumors and brain metastases in one treatment.

Released: 6-May-2024 2:05 PM EDT
Nova ferramenta dos pesquisadores da Mayo Clinic associa os tipos de doença de Alzheimer à taxa de declínio cognitivo
Mayo Clinic

A utilização de uma nova ferramenta que utiliza dados tridimensionais, fez com que pesquisadores da Mayo Clinic descobrissem uma série de alterações cerebrais na doença de Alzheimer caracterizadas por aspectos clínicos únicos e comportamentais das células imunológicas.

Released: 6-May-2024 2:05 PM EDT
تربط أداة جديدة ابتكرها باحثو مايو كلينك بين أنواع داء الزهايمر ومعدل الانحدار الإدراكي
Mayo Clinic

باستخدام أداة جديدة تكرس بيانات ثلاثية الأبعاد، اكتشف باحثو مايو كلينك سلسلة من التغيرات الدماغية يسببها داء الزهايمر تتسم بخصائص سريرية وسلوكية فريدة للخلايا المناعية.

Released: 6-May-2024 2:05 PM EDT
New Physicians’ Exam Scores Tied to Patient Survival
Harvard Medical School

How well a newly minted doctor scores on their medical board exam appears linked to patients’ odds of dying or being readmitted to the hospital. Findings offer reassurance that certification exams, which aim to demonstrate the competence of physicians, capture critical knowledge and clinical judgment skills for physicians.

Newswise: Two Hackensack Meridian Health Leaders To Be Honored by American Academy of Pediatrics for Improving the Lives of Children and Families
Released: 6-May-2024 2:05 PM EDT
Two Hackensack Meridian Health Leaders To Be Honored by American Academy of Pediatrics for Improving the Lives of Children and Families
Hackensack Meridian Health

Two leaders from Hackensack Meridian Health will be honored by the New Jersey Chapter of the American Academy of Pediatrics (NJAAP) at an upcoming event.

Released: 6-May-2024 2:05 PM EDT
TCT 2024 Master Operator Award to Be Presented to Jeffrey W. Moses, MD
Cardiovascular Research Foundation (CRF)

The TCT Geoffrey O. Hartzler Master Operator Award will be presented to Jeffrey W. Moses, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 27-30, 2024, in Washington, DC, at the Walter E. Washington Convention Center.

Released: 6-May-2024 2:05 PM EDT
Nueva herramienta de los investigadores de Mayo Clinic vincula los tipos de enfermedad de Alzheimer con la tasa de deterioro cognitivo
Mayo Clinic

El uso de una nueva herramienta que utiliza datos tridimensionales, hizo que los investigadores de Mayo Clinic descubrieran una serie de cambios cerebrales en la enfermedad de Alzheimer caracterizadas por aspectos clínicos únicos y conductuales de las células inmunitarias.

Newswise: NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by People with Cancer
Released: 6-May-2024 2:00 PM EDT
NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by People with Cancer
National Comprehensive Cancer Network® (NCCN®)

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—hosts an oncology policy summit focused on how sexual and reproductive health can impact people with cancer before, during, and after treatment.

Newswise: Wetter Recognized for Exemplary Leadership in Cancer Equity Initiatives
Released: 6-May-2024 1:05 PM EDT
Wetter Recognized for Exemplary Leadership in Cancer Equity Initiatives
Huntsman Cancer Institute at the University of Utah

David Wetter, PhD, has been honored for pioneering cancer health equity strategies, transforming research into practical solutions, and fostering vital community partnerships for underserved populations and rural communities.

Released: 6-May-2024 12:05 PM EDT
Using Advanced Genetic Techniques, Scientists Create Mice With Traits of Tourette Disorder
Rutgers University-New Brunswick

In research that may be a step forward toward finding personalized treatments for Tourette disorder, scientists at Rutgers University–New Brunswick have bred mice that exhibit some of the same behaviors and brain abnormalities seen in humans with the disorder. As reported in the Proceedings of the National Academy of Sciences, the researchers, using a technique known as CRISPR/Cas9 DNA editing, inserted the same genetic mutations found in humans with Tourette disorder into the corresponding genes in mouse embryos.

Released: 6-May-2024 12:05 PM EDT
Association for Molecular Pathology to Provide Preliminary Analysis of the FDA’s Final Rule on Laboratory Developed Testing Procedures
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, will host a free webinar on the US Food and Drug Administration (FDA) final rule that seeks to regulate laboratory developed tests (LDTs) as medical devices.

Released: 6-May-2024 12:00 PM EDT
Now Available from Penn Nursing: Innovative, Online Psychedelic Course
University of Pennsylvania School of Nursing

Penn Nursing is proud to launch a groundbreaking new online course – Educating Nurses in Psychedelic Assisted Therapy – via Open Canvas.

Released: 6-May-2024 11:30 AM EDT
Society for Clinical Trials Presents E-MOTIVE Trial with Prestigious David Sackett Trial of the Year Award
Society for Clinical Trials

The Society for Clinical Trials (SCT) is pleased to announce that the prestigious David Sackett Trial of the Year Award will be presented to the ”Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage (E-MOTIVE).”

Released: 6-May-2024 11:30 AM EDT
Dana-Farber review article examines past and guides future efforts to reduce cancer disparities
Dana-Farber Cancer Institute

Investigators at Dana-Farber Cancer Institute have examined the historical evolution of Community Outreach and Engagement initiatives at both the National Cancer Institute (NCI) and National Cancer Institute-Designated Cancer Centers (NCI-DCCs).

Released: 6-May-2024 11:05 AM EDT
Mindfulness Training Enhances Opioid Addiction Treatment
Rutgers University-New Brunswick

Rutgers Health trial shows mindfulness training during treatment reduces dropouts and relapses.

Newswise: Sharing the Wealth
Released: 6-May-2024 11:05 AM EDT
Sharing the Wealth
University of New Mexico Comprehensive Cancer Center

A cancer diagnosis scares most people. Those outside of large population centers like Albuquerque have the additional concern of having to travel to get timely, specialized medical treatment. Now, a new program at The University of New Mexico Comprehensive Cancer Center aims to streamline the process for all New Mexicans, regardless of where they live in the state.

Newswise: ER patient portal usage increasing, study shows
Released: 6-May-2024 11:05 AM EDT
ER patient portal usage increasing, study shows
UT Southwestern Medical Center

More people are using online patient portals to view their information while in the emergency room, but access is challenging for members of medically underserved communities and the elderly, UT Southwestern Medical Center researchers and national colleagues found in a new study.

Newswise:Video Embedded cutting-edge-tech-gives-students-a-3d-look-at-anatomy
VIDEO
Released: 6-May-2024 11:05 AM EDT
Cutting-edge tech gives students a 3D look at anatomy
University of Delaware

University of Delaware students had the ability to get a first-time, hands-on encounter with anatomy thanks to new virtual anatomy tables that can isolate ligaments, tissues, and arteries in the hand. UD is one of few schools in the country to offer this cutting-edge tech.

Released: 6-May-2024 10:05 AM EDT
AANA Celebrates National Nurses Week, Honoring the Vital Contributions of CRNAs
American Association of Nurse Anesthesiology

The American Association of Nurse Anesthesiology (AANA) proudly joins the nation in celebrating the dedication, compassion, and expertise of all nurses during National Nurses Week, May 6- 12, 2024. During this week, AANA recognizes the invaluable contributions of all nurses, particularly highlighting the essential role played by Certified Registered Nurse Anesthetists (CRNAs), also known as nurse anesthesiologists or nurse anesthetists, in delivering quality patient care.

Newswise: Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and— eventually—treatment
Released: 6-May-2024 10:05 AM EDT
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and— eventually—treatment
Michigan Medicine - University of Michigan

A new study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas.

Released: 6-May-2024 10:05 AM EDT
Ochsner Health designated 'WellSpot' by La. Dept. of Health
Ochsner Health

WellSpot is the first voluntary designation program of its kind in Louisiana, encouraging organizations and individuals to make small, healthy lifestyle changes in spaces where residents spend most of their time.

Newswise: Belfer family’s $20 million donation invigorates neurodegeneration research at MD Anderson
Released: 6-May-2024 10:00 AM EDT
Belfer family’s $20 million donation invigorates neurodegeneration research at MD Anderson
University of Texas MD Anderson Cancer Center

Laurence Belfer, on behalf of Robert Belfer and the Belfer family, today announced a $20 million gift to The University of Texas MD Anderson Cancer Center to strengthen neurodegeneration research through the Belfer Neurodegeneration Consortium (BNDC), a transformative multi-institutional initiative to advance the study and treatment of Alzheimer’s disease.

Released: 6-May-2024 9:05 AM EDT
How to Help Your Child Make Friends With a Child Who Has Autism
Children's Hospital Los Angeles

As a parent, you want your child to be inclusive and accepting of the people they encounter—including those with autism spectrum disorder. Approximately 95% of children with disabilities enroll in regular schools. That means your child is likely to meet someone with autism in class or extracurricular activities, whether they realize it or not.

Released: 6-May-2024 9:05 AM EDT
Study Uncovers At Least One Cause of Roadblocks to Cancer Immunotherapy
Yale Cancer Center/Smilow Cancer Hospital

A study led by Yale scientists, published April 25 in the journal Science Immunology, investigated the potential causes associated with T cell exclusion using a genome-wide screen of more than 1,000 human proteins.

Released: 6-May-2024 9:05 AM EDT
Memorial Sloan Kettering Cancer Center Launches Innovative Projects to Improve Health in Queens and Brooklyn
Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) today announced an innovative set of initiatives to support underserved communities in New York City who lack access to cancer screening and early detection. With critical support from longtime MSK Board Member Bruce Ratner, the Ratner Early Detection Initiative (REDI) draws from MSK’s deep experience in cancer science and discovery, community engagement, and compassionate patient care.

Newswise: Beyond Therapy: Virtual Reality Shows Promise in Fighting Depression
Released: 6-May-2024 9:00 AM EDT
Beyond Therapy: Virtual Reality Shows Promise in Fighting Depression
JMIR Publications

Study reveals VR's potential in revolutionizing depression treatment, offering hope to millions worldwide.

   
Released: 6-May-2024 8:05 AM EDT
Quietly making noise: Measuring differential privacy could balance meaningful analytics and healthcare data security
Oak Ridge National Laboratory

ORNL researchers Vandy Tombs and Robert Bridges have developed a new method that improves on the standard method of differential privacy to allow healthcare data sharing while maintaining patient privacy.

   
5-May-2024 7:05 PM EDT
Research to Prevent Blindness Opens Applications for Vision Research Grants
Research to Prevent Blindness

Research to Prevent Blindness is pleased to announce that it has opened a new round of grant funding for high-impact vision research, including research related to glaucoma, age-related macular degeneration, inherited retinal diseases, myopia, amblyopia, low vision and many more.

Newswise: Simulated Chemistry: New AI Platform Designs Tomorrow’s Cancer Drugs
1-May-2024 10:05 AM EDT
Simulated Chemistry: New AI Platform Designs Tomorrow’s Cancer Drugs
University of California San Diego

Researchers from University of California San Diego have developed a new AI tool to that generate new drug candidates for cancer, which could help streamline the typically laborious drug discovery process.

Released: 6-May-2024 4:05 AM EDT
In a first, researchers generate a direct measurement of the interaction between immune cells and cancer cells from a patient’s biopsy
Bar-Ilan University

Researchers at Bar-Ilan University have unveiled a technology that promises to improve cancer treatment decisions based on a patient's biopsy.

   


close
1.33618